It represents a scientifically determined window where, assuming proper refrigerated storage and sterile technique, the benzyl alcohol can reliably maintain the sterility of the solution despite multiple punctures of the stopper
Timelines vary by person, goal, and protocol
Phase 3 trials have shown a side-effect profile in line with other GLP-1 drugs
At our clinic, patients who come in with chronic GI inflammation, SIBO residuals, or a history of NSAID-induced gastritis are the group most likely to report subjective improvement on BPC-157 within the first 30 days
The compound did not appear to affect food intake, behavior, or general health status in treated animals
The results come from the preclinical literature